J Am Coll Cardiol December 2018 PMID 30545448

Prevention of Arrhythmia Device Infection Trial: The PADIT Trial.

Andrew D Krahn, Yves Longtin, François Philippon, David H Birnie, Jaimie Manlucu, Paul Angaran, Claus Rinne, Benoit Coutu, R Aaron Low, Vidal Essebag, Carlos Morillo, Damian Redfearn, Satish Toal, Giuliano Becker, Michel Degrâce

Mentions

31
Peak: 13 in Jan 2019
across 4 sources since Jan 2019

Extended reach

51,749
potential audience

Total likes

81

Video views

3,719

Mentions per month

Jan 2019 – Nov 2023

Where it's discussed

  • X / Twitter18 posts
  • News9 articles
  • YouTube2 videos
  • Facebook2 posts

AI synopsis

What people are saying

The proposed discussions reflect a balanced attitude towards the study, with participants noting the low infection rates and the absence of statistically significant differences, as seen in phrases like 'not significant' and 'quite convinced.' The tone remains analytical rather than emotional, with some users referencing specific antibiotic practices or trial methods, contributing to a moderate level of interest and engagement.

AgreementModerate agreement

Most discussions acknowledge the findings of the PADIT trial, noting the low infection rates and the lack of significant difference between treatment groups.

InterestModerate interest

Participants show moderate interest, with some expressing curiosity about specific methods and implications but largely focusing on confirming the study's outcomes.

EngagementModerate engagement

Comments involve some technical details, referencing antibiotic protocols and infection rates, indicating an average level of engagement.

ImpactNeutral impact

The discussions suggest limited immediate practical impact since the study findings show minimal difference in outcomes, although they highlight ongoing debates about antibiotic strategies.

Abstract in brief

  • • The results showed a slight reduction in device infections with the incremental antibiotic approach, especially in high-risk patients, but the difference was not statistically significant.
  • • Overall, the study suggests that while more comprehensive antibiotic protocols might help, they did not significantly decrease infection rates, and infection rates remained low across both treatment groups.

Top posts

Most liked on X and Bluesky
Asociación del Ritmo Cardiaco
@ritmo_SEC · X

¿Podría una profilaxis antibiótica más amplia (que la terapia convencional con cefazolina) ⬇️ las infecciones de dispositivos cardiacos #DECI ? #PADIT trial. https://t.co/FJiXFHr58S Nueva revisión del artículo publicado recientemente en @JACCJournals https://t.co/F4HVmBpCwW https://t.co/D1DDIQkgR1

Jan 9, 2019 · 8 likes · 7 shares · 2,521 followers View post →
Mark McIntyre, Pharm.D
@ASP_Mark · X

More antibiotics, not always a better outcome. NS difference in infection rates in this large, multisite trial of SOC vs. SOC+irrigation with antibiotcs+post-op abx Prevention of Arrhythmia Device Infection Trial: The PADIT Trial https://t.co/A6iK0nnP1N

May 20, 2020 · 5 likes · 993 followers View post →
Julian P Villacastin
@jvillacastin · X

Prevention of Arrhythmia Device Infection Trial. The PADIT Trial Device infection rates were low. The observed difference in infection rates was not statistically significant. https://t.co/Oo8bBXwo1d https://t.co/EvjtmOzvto

Jan 8, 2019 · 4 likes · 5 shares · 23,540 followers View post →
Patrick Dillon
@PatDillonMD · X

@haripj152 @rdschaller @narrowQRS @drrakeshg1 @Hisdoc1 As a group we use saline wash in pocket, and not ABX wash or post procedure ABX course. https://t.co/gvvtaV5nlO

Mar 11, 2022 · 2 likes · 667 followers View post →
Shanta Chakrabarti
@SchakrabartiEP · X

@doc_ccc @cellisvandyep In our PADIT study, in high-risk patients, hospitalization for infection occurred 1.23% receiving conventional antibiotics and 1.01% receiving incremental antibiotics ( p = 0.26). We did not use any antibiotic envelope. https://t.co/lhO2WJ151c @EPeeps_Bot

Mar 26, 2023 · 1 like · 4,204 followers View post →
David Duncker
@DavidDuncker · X

@malagu_m @EHRAPresident @Dominik_Linz @GuerraCardio @escardio @RodrigueGarcia4 @KommataVarvara @HaranBurri Not sure. But quite convinced. https://t.co/PBRr7TuGJx

Feb 2, 2022 · 1 like · 3,651 followers View post →

All mentions

Shanta Chakrabarti
@SchakrabartiEP · X

@doc_ccc @cellisvandyep In our PADIT study, in high-risk patients, hospitalization for infection occurred 1.23% receiving conventional antibiotics and 1.01% receiving incremental antibiotics ( p = 0.26). We did not use any antibiotic envelope. https://t.co/lhO2WJ151c @EPeeps_Bot

Mar 26, 2023 · 1 like · 4,204 followers View post →
Patrick Dillon
@PatDillonMD · X

@haripj152 @rdschaller @narrowQRS @drrakeshg1 @Hisdoc1 As a group we use saline wash in pocket, and not ABX wash or post procedure ABX course. https://t.co/gvvtaV5nlO

Mar 11, 2022 · 2 likes · 667 followers View post →
David Duncker
@DavidDuncker · X

@malagu_m @EHRAPresident @Dominik_Linz @GuerraCardio @escardio @RodrigueGarcia4 @KommataVarvara @HaranBurri Not sure. But quite convinced. https://t.co/PBRr7TuGJx

Feb 2, 2022 · 1 like · 3,651 followers View post →
J Dylan Hall, MD
@J_Dylan_Hall · X

@SMParrishRPh @IdVilchez @IDstewardship Single dose cefazolin pre-procedure and done. https://t.co/bG3AvPBacl

May 5, 2021 · 1 like · 195 followers View post →
Mark McIntyre, Pharm.D
@ASP_Mark · X

More antibiotics, not always a better outcome. NS difference in infection rates in this large, multisite trial of SOC vs. SOC+irrigation with antibiotcs+post-op abx Prevention of Arrhythmia Device Infection Trial: The PADIT Trial https://t.co/A6iK0nnP1N

May 20, 2020 · 5 likes · 993 followers View post →
maite grande osorio
@maitegrandeosor · X

RT @estimcardiaca: ¿Podría una profilaxis antibiótica más amplia (que la terapia convencional con cefazolina) ⬇️ las infecciones de disposi…

Jan 17, 2019 · 7 shares · 68 followers View post →
Ivan Betancor
@ivanhbet · X

RT @estimcardiaca: ¿Podría una profilaxis antibiótica más amplia (que la terapia convencional con cefazolina) ⬇️ las infecciones de disposi…

Jan 10, 2019 · 7 shares · 397 followers View post →
Asociación del Ritmo Cardiaco
@ritmo_SEC · X

RT @estimcardiaca: ¿Podría una profilaxis antibiótica más amplia (que la terapia convencional con cefazolina) ⬇️ las infecciones de disposi…

Jan 10, 2019 · 7 shares · 2,521 followers View post →
Óscar Cano
@OCanoPerez · X

RT @estimcardiaca: ¿Podría una profilaxis antibiótica más amplia (que la terapia convencional con cefazolina) ⬇️ las infecciones de disposi…

Jan 9, 2019 · 7 shares · 1,996 followers View post →
Isabel M. Lillo
@imlillo · X

RT @estimcardiaca: ¿Podría una profilaxis antibiótica más amplia (que la terapia convencional con cefazolina) ⬇️ las infecciones de disposi…

Jan 9, 2019 · 7 shares · 346 followers View post →
Manuel Molina-Lerma
@ManoloMolina8 · X

RT @estimcardiaca: ¿Podría una profilaxis antibiótica más amplia (que la terapia convencional con cefazolina) ⬇️ las infecciones de disposi…

Jan 9, 2019 · 7 shares · 439 followers View post →
Javier Chimeno
@javierchimeno · X

RT @estimcardiaca: ¿Podría una profilaxis antibiótica más amplia (que la terapia convencional con cefazolina) ⬇️ las infecciones de disposi…

Jan 9, 2019 · 7 shares · 502 followers View post →
Asociación del Ritmo Cardiaco
@ritmo_SEC · X

¿Podría una profilaxis antibiótica más amplia (que la terapia convencional con cefazolina) ⬇️ las infecciones de dispositivos cardiacos #DECI ? #PADIT trial. https://t.co/FJiXFHr58S Nueva revisión del artículo publicado recientemente en @JACCJournals https://t.co/F4HVmBpCwW https://t.co/D1DDIQkgR1

Jan 9, 2019 · 8 likes · 7 shares · 2,521 followers View post →
LUISITO
@LUISITOVALL · X

RT @jvillacastin: Prevention of Arrhythmia Device Infection Trial. The PADIT Trial Device infection rates were low. The observed difference…

Jan 9, 2019 · 5 shares · 7 followers View post →
Jorge Bustos 
@JORARTU · X

RT @jvillacastin: Prevention of Arrhythmia Device Infection Trial. The PADIT Trial Device infection rates were low. The observed difference…

Jan 8, 2019 · 5 shares · 457 followers View post →
Pablo Casanova
@DrCasanovaPablo · X

RT @jvillacastin: Prevention of Arrhythmia Device Infection Trial. The PADIT Trial Device infection rates were low. The observed difference…

Jan 8, 2019 · 5 shares · 4,912 followers View post →
DULCINEA
@DulLedezma · X

RT @jvillacastin: Prevention of Arrhythmia Device Infection Trial. The PADIT Trial Device infection rates were low. The observed difference…

Jan 8, 2019 · 5 shares · 453 followers View post →
Julian P Villacastin
@jvillacastin · X

Prevention of Arrhythmia Device Infection Trial. The PADIT Trial Device infection rates were low. The observed difference in infection rates was not statistically significant. https://t.co/Oo8bBXwo1d https://t.co/EvjtmOzvto

Jan 8, 2019 · 4 likes · 5 shares · 23,540 followers View post →